BMY May 2025 52.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:30PM EDT. Market open.
Loading interactive chart…
- Business Wire
European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
- Business Wire
Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024
- Zacks
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Bristol Myers Squibb (BMY) concluded the recent trading session at $40.81, signifying a -0.39% move from its prior day's close.
© 2024 Yahoo. All rights reserved.